ACADIA Pharmaceuticals Inc. (ACAD)
Total Valuation
ACAD has a market cap or net worth of $5.14 billion. The enterprise value is $4.84 billion.
| Market Cap | 5.14B |
| Enterprise Value | 4.84B |
Important Dates
The next estimated earnings date is Monday, February 26, 2024, after market close.
| Earnings Date | Feb 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 164.18 million shares outstanding. The number of shares has increased by 1.47% in one year.
| Shares Outstanding | 164.18M |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 98.19% |
| Float | 109.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.11 |
| PS Ratio | 8.14 |
| Forward PS | 5.24 |
| PB Ratio | 14.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.42 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.38 |
| Quick Ratio | 2.13 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.80% and return on invested capital (ROIC) is -37.63%.
| Return on Equity (ROE) | -38.80% |
| Return on Assets (ROA) | -23.60% |
| Return on Capital (ROIC) | -37.63% |
| Revenue Per Employee | $1.23M |
| Profits Per Employee | -$289,510 |
| Employee Count | 514 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, ACAD has paid $17.18 million in taxes.
| Income Tax | 17.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.30% in the last 52 weeks. The beta is 0.59, so ACAD's price volatility has been lower than the market average.
| Beta (1Y) | 0.59 |
| 52-Week Price Change | +96.30% |
| 50-Day Moving Average | 24.25 |
| 200-Day Moving Average | 24.11 |
| Relative Strength Index (RSI) | 72.16 |
| Average Volume (30 Days) | 1,728,372 |
Short Selling Information
The latest short interest is 7.69 million, so 4.68% of the outstanding shares have been sold short.
| Short Interest | 7.69M |
| Short Previous Month | 7.73M |
| Short % of Shares Out | 4.68% |
| Short % of Float | 7.05% |
| Short Ratio (days to cover) | 3.73 |
Income Statement
In the last 12 months, ACAD had revenue of $631.89 million and -$148.81 million in losses. Loss per share was -$0.92.
| Revenue | 631.89M |
| Gross Profit | 605.73M |
| Operating Income | -154.39M |
| Pretax Income | -131.63M |
| Net Income | -148.81M |
| EBITDA | -127.23M |
| EBIT | -131.63M |
| Loss Per Share | -$0.92 |
Balance Sheet
The company has $351.69 million in cash and $48.10 million in debt, giving a net cash position of $303.59 million or $1.85 per share.
| Cash & Cash Equivalents | 351.69M |
| Total Debt | 48.10M |
| Net Cash | 303.59M |
| Net Cash Per Share | $1.85 |
| Equity / Book Value | 362.17M |
| Book Value Per Share | 2.21 |
| Working Capital | 289.57M |
Cash Flow
In the last 12 months, operating cash flow was -$92.54 million and capital expenditures -$50,000, giving a free cash flow of -$92.59 million.
| Operating Cash Flow | -92.54M |
| Capital Expenditures | -50,000 |
| Free Cash Flow | -92.59M |
| FCF Per Share | -$0.56 |
Margins
Gross margin is 95.86%, with operating and profit margins of -24.43% and -23.55%.
| Gross Margin | 95.86% |
| Operating Margin | -24.43% |
| Pretax Margin | -20.83% |
| Profit Margin | -23.55% |
| EBITDA Margin | -20.13% |
| EBIT Margin | -20.83% |
| FCF Margin | -14.65% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -2.89% |
| FCF Yield | -1.80% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.47% |
Analyst Forecast
The average price target for ACAD is $32.72, which is 4.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.72 |
| Price Target Difference | 4.50% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 22.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 6.79 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.79 |
| Piotroski F-Score | 3 |